The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft

This investigative pilot study was conducted with the objective of evaluating the therapeutic effect of a cream containing hyaluronic acid (HA) and silver-sulfadiazine (Altergen®, IBSA Farmaceutici Italia, S.r.l.) in adult patients undergoing two-stage urethroplasty using an oral mucosal graft for a...

Full description

Bibliographic Details
Main Authors: G. Romano, G. Barbagli, M. Lazzeri
Format: Article
Language:English
Published: SAGE Publishing 2011-05-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1100900211
id doaj-115b237671174cefa4c1ec69c649537b
record_format Article
spelling doaj-115b237671174cefa4c1ec69c649537b2020-11-25T03:01:07ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2011-05-01910.1177/1721727X1100900211The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal GraftG. Romano0G. Barbagli1M. Lazzeri2 Department of Urology, San Donato Hospital, Arezzo Center for Reconstructive Urethral Surgery, Arezzo Clinical Research Institute “Prof. M. Fanfani”, Florence, ItalyThis investigative pilot study was conducted with the objective of evaluating the therapeutic effect of a cream containing hyaluronic acid (HA) and silver-sulfadiazine (Altergen®, IBSA Farmaceutici Italia, S.r.l.) in adult patients undergoing two-stage urethroplasty using an oral mucosal graft for anterior urethral strictures due to failed hypospadias repair. We used a cream (Altergen®) containing the following active ingredients: 100 g HA, 0.20 mg sodium salt, and 1 g silver-sulfadiazine. During the period of January 2009 - May 2010, 40 patients, mean age 24 years, who had undergone hypospadias surgery during childhood were enrolled in the study, according to some inclusion and exclusion criteria (age >18 years, with the absence of diabetes, neurovascular disease, lichen sclerosus or other dermatological lesions). All 40 patients had navicularis or penile urethral strictures and underwent two-stage urethroplasty using an oral mucosa graft. Post-operatively, 20 patients (50%) were treated with a cream containing HA and silver-sulfadiazine (Altergen®) and 20 patients (50%) were treated using a standard topical treatment (iodopovidone 10% gel). All patients underwent a follow-up at 6, 15, 30, 60 and 120 days after surgery. Out of the 20 patients treated with the HA and silver-sulfadiazine-containing cream (Altergen®), 18 (90%) showed good and complete healing of the graft implant 30 days after surgery. Of the 20 patients not treated with the HA and silver-sulfadiazine-contaning cream (Altergen®), 13 (65%) showed good and complete healing of the graft implant 30 days after surgery. These results were constant in all follow-ups in both patient groups. In patients who underwent a navicularis or penile two-stage oral mucosal graft urethroplasty, the use of a HA and silver-sulfadiazine-containing cream was associated with a higher success rate of the graft implant and a lower incidence of post-surgical complications compared to the controls.https://doi.org/10.1177/1721727X1100900211
collection DOAJ
language English
format Article
sources DOAJ
author G. Romano
G. Barbagli
M. Lazzeri
spellingShingle G. Romano
G. Barbagli
M. Lazzeri
The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
European Journal of Inflammation
author_facet G. Romano
G. Barbagli
M. Lazzeri
author_sort G. Romano
title The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
title_short The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
title_full The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
title_fullStr The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
title_full_unstemmed The Use of Topical Hyaluronic Acid and Silver Sulfadiazine (Altergen®) in Patients Undergoing Two-Stage Anterior Urethroplasty with Oral Mucosal Graft
title_sort use of topical hyaluronic acid and silver sulfadiazine (altergen®) in patients undergoing two-stage anterior urethroplasty with oral mucosal graft
publisher SAGE Publishing
series European Journal of Inflammation
issn 1721-727X
publishDate 2011-05-01
description This investigative pilot study was conducted with the objective of evaluating the therapeutic effect of a cream containing hyaluronic acid (HA) and silver-sulfadiazine (Altergen®, IBSA Farmaceutici Italia, S.r.l.) in adult patients undergoing two-stage urethroplasty using an oral mucosal graft for anterior urethral strictures due to failed hypospadias repair. We used a cream (Altergen®) containing the following active ingredients: 100 g HA, 0.20 mg sodium salt, and 1 g silver-sulfadiazine. During the period of January 2009 - May 2010, 40 patients, mean age 24 years, who had undergone hypospadias surgery during childhood were enrolled in the study, according to some inclusion and exclusion criteria (age >18 years, with the absence of diabetes, neurovascular disease, lichen sclerosus or other dermatological lesions). All 40 patients had navicularis or penile urethral strictures and underwent two-stage urethroplasty using an oral mucosa graft. Post-operatively, 20 patients (50%) were treated with a cream containing HA and silver-sulfadiazine (Altergen®) and 20 patients (50%) were treated using a standard topical treatment (iodopovidone 10% gel). All patients underwent a follow-up at 6, 15, 30, 60 and 120 days after surgery. Out of the 20 patients treated with the HA and silver-sulfadiazine-containing cream (Altergen®), 18 (90%) showed good and complete healing of the graft implant 30 days after surgery. Of the 20 patients not treated with the HA and silver-sulfadiazine-contaning cream (Altergen®), 13 (65%) showed good and complete healing of the graft implant 30 days after surgery. These results were constant in all follow-ups in both patient groups. In patients who underwent a navicularis or penile two-stage oral mucosal graft urethroplasty, the use of a HA and silver-sulfadiazine-containing cream was associated with a higher success rate of the graft implant and a lower incidence of post-surgical complications compared to the controls.
url https://doi.org/10.1177/1721727X1100900211
work_keys_str_mv AT gromano theuseoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
AT gbarbagli theuseoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
AT mlazzeri theuseoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
AT gromano useoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
AT gbarbagli useoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
AT mlazzeri useoftopicalhyaluronicacidandsilversulfadiazinealtergeninpatientsundergoingtwostageanteriorurethroplastywithoralmucosalgraft
_version_ 1724694869928050688